#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma Corneal neovascularisation Antiphospholipid antibodies Chronic granulomatous disease Biliary neoplasm Paraneoplastic neurological syndrome Squamous cell carcinoma of the oral cavity Choroidal dystrophy Ichthyosis Adrenoleukodystrophy Synovial sarcoma recurrent VEXAS syndrome Hepatitis B Meningitis meningococcal Vitamin B12 deficiency More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Life with Disease Progressive supranuclear palsy Skin angiosarcoma – Life with Disease Hereditary angioedema – Trials in Disease Crigler-Najjar syndrome – Life with Disease KBG syndrome – Basic Information IgA nephropathy – Treatment Adrenocortical carcinoma Hereditary optic atrophy – Basic Information Activated PI3 kinase delta syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azd5492 THEOPHYLLINE ANHYDROUS Inotuzumab Ozogamicin Daridorexant Clarithromycin Neostigmine Methylsulfate Avelumab Escitalopram Trimetazidine Dihydrochloride Corifollitropin Alfa Liraglutide Glucose Monohydrate Ph. Eur. Briquilimab Travoprost Potassium Inupadenant Minocycline Hydrochloride Carbamazepine (Ph. Eur.) Anhydrous Glucose Bp Plerixafor More therapies…

    Learn about Your Condition

    Endometriosis Myasthenia gravis Marginal zone lymphoma Mixed dementia Macular telangiectasia Growth hormone deficiency Mumps Laparoscopic surgery Coronary artery bypass Andersen-Tawil syndrome Mechanical ventilation Colour blindness Iron overload Pharyngeal cancer stage I Lymphoedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Levothyroxine and Liothyronine for Patients with Autoimmune Hypothyroidism and Persistent Tiredness

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypothyroidism
    The Netherlands

  • Study on Lithium Carbonate for Patients with TBR1-Related Neurocognitive Disorder

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    Investigated Drugs:
    • Lithium Carbonate
    France

  • Study on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Generalised anxiety disorder
    Investigated Drugs:
    • Iti-1284
    Bulgaria Czechia Finland Poland

  • Study on Norfloxacin for Reducing Portal Hypertension in Patients with Decompensated Cirrhosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Portal hypertension
    • Hepatic cirrhosis
    Investigated Drugs:
    • Norfloxacin
    Austria

  • Study of Lutetium (177Lu) Oxodotreotide for Patients with Recurrent Meningioma Without Surgery or Radiotherapy Options

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Meningioma
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Octreotide Acetate
    • Everolimus
    Austria Denmark France Germany Italy The Netherlands +2

  • Study on [18F]Fluoro-PEG-Folate PET-CT Imaging to Monitor Therapy Response in Patients with Rheumatoid Arthritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • [18F]Fluoro-Peg-Folate
    The Netherlands
Previous Page
1 … 303 304 305 306 307 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!